Antimicrobial resistance (AMR) in Neisseria gonorrhoeae (NG) is an urgent global health concern. Commensal Neisseria species in the oropharynx are an important reservoir of AMR genes that are transferred to NG, yet few data about AMR among commensal Neisseria in populations at risk for AMR exist. From May 2022 - December 2023, men in a HIV pre-exposure prophylaxis program in Hanoi, Vietnam, were recruited. Participants self-collected oral specimens using phosphate buffer solution (PBS), for culture on LB agar media containing sucrose, vancomycin and trimethoprim (LBVT.SNR). Oxidase-positive gram-negative diplococci were identified using Remel RapID NH system. Minimum inhibitory concentrations (MICs) to azithromycin, ceftriaxone, cefixime, and doxycycline were determined using Etests. There were 42 male participants, the median age was 26 years and 29% (n=12) reported using antibiotics in the past 6 months. In total, 48 Neisseria isolates were recovered; N. sicca/subflava was the most common species (50%; n=24), followed by N. mucosa (38%; n=18). For azithromycin, 85% (n=41) of isolates were resistant with MICs ≥1 ug/ml, including 25% (n=12) with high-level resistance (MICs ≥ 256 ug/mL of which 67% (8/12) were N. mucosa. Among non-gonococcal Neisseria isolates, the prevalence of resistance was 6% (n=3) for ceftriaxone, 6% (n=3) for cefixime, and 54% (n=26) for doxycycline; most non-susceptible isolates were N. mucosa. A High frequency of azithromycin resistance, moderate doxycycline resistance, and low cephalosporin resistance was found in oropharyngeal Neisseria isolates from MSM in a PrEP program in Hanoi, Vietnam. N. mucosa was over-represented among resistant isolates.
Read full abstract